| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.979 | 27.152 | 25.740 | 21.100 | 224 | 881 | 861 | 864 | 861 | 0 |
| Total Income - EUR | 19.988 | 27.160 | 25.740 | 21.100 | 224 | 881 | 861 | 864 | 861 | 0 |
| Total Expenses - EUR | 15.916 | 21.305 | 24.581 | 18.449 | 1.627 | 929 | 707 | 951 | 824 | 158 |
| Gross Profit/Loss - EUR | 4.072 | 5.855 | 1.159 | 2.651 | -1.403 | -48 | 154 | -87 | 37 | -158 |
| Net Profit/Loss - EUR | 3.470 | 5.044 | 383 | 2.014 | -1.410 | -73 | 128 | -113 | 24 | -158 |
| Employees | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medfania Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 10.143 | 13.174 | 13.873 | 7.590 | 5.980 | 5.762 | 5.762 | 5.667 | 5.619 | 5.480 |
| Inventories | 8.281 | 4.788 | 5.075 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 29 | 29 |
| Cash | 1.862 | 8.386 | 8.798 | 7.590 | 5.980 | 5.761 | 5.761 | 5.666 | 5.589 | 5.451 |
| Shareholders Funds | 5.478 | 10.466 | 10.672 | 7.515 | 5.959 | 5.773 | 5.773 | 5.678 | 5.685 | 5.495 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.665 | 2.708 | 3.201 | 75 | 21 | -11 | -11 | -11 | -67 | -15 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Medfania Srl